Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F13%3A00212773" target="_blank" >RIV/62156489:43210/13:00212773 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.3390/ijms140713391" target="_blank" >http://dx.doi.org/10.3390/ijms140713391</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/ijms140713391" target="_blank" >10.3390/ijms140713391</a>

Result language
angličtina
Original language name
Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery
Original language description
Magnetic particle mediated transport in combination with nanomaterial based drug carrier has a great potential for targeted cancer therapy. In this study, doxorubicin encapsulation into the apoferritin and its conjugation with magnetic particles was investigated by capillary electrophoresis with laser-induced fluorescence detection (CE-LIF). The quantification of encapsulated doxorubicin was performed by fluorescence spectroscopy and compared to CE-LIF. Moreover, the significant enhancement of the doxorubicin signal was observed by addition of methanol into the sample solution.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—

Project
<a href="/en/project/GAP301%2F10%2F0356" target="_blank" >GAP301/10/0356: Study of contribution of different DNA-damaging mechanisms to toxicity of cytostatics to human chemosensitive and chemoresistant neuroblastomas</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)